K-134 is a PDE3 inhibitor potentially for the treatment of anti-thrombotic and anti-hyperplastic activities. References: Sasaki Y, Suzuki H, Itoh S, Yoshida H, Kondo S, Inoue K, Tanabe S. K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models. Eur J Pharmacol. 2012 Aug 15;689(1-3):132-8. doi: 10.1016/j.ejphar.2012.05.014. Epub 2012 May 31. PubMed PMID: 22659587.
纯度:≥98%
CAS:189362-06-9